BiotechTube
Home/PharmaMar/Pablo G. de María
PG

Pablo G. de María

Chief Business Officer

PharmaMar

Therapeutic Areas

Oncology

PharmaMar Pipeline

DrugIndicationPhase
Yondelis (trabectedin)Soft Tissue Sarcoma, Ovarian CancerApproved
Zepzelca (lurbinectedin)Metastatic Small Cell Lung Cancer (SCLC)Approved
PM14Advanced Solid TumorsPhase 1/2

Leadership Team at PharmaMar

JM
José María Fernández Sousa-Faro
President & Founder
LM
Luis Mora
Chief Operating Officer
View full PharmaMar profile